推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

CANCER SCIENCE

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 CANCER SCI最新评论:被它拒的综述已经被一个比它还高一分多的期刊录用了,而且保留了我的全部原文字数,干脆利索,收到返修,修改后不到一个月直接录... (2024-10-28)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


CANCER SCIENCE期刊基本信息Hello,您是该期刊的第147972位访客

基本信息 登录收藏
期刊名字CANCER SCIENCECANCER SCIENCE

CANCER SCI
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
7.4
54人评分
我要评分

声誉
8.1

影响力
6.6

速度
9.0

期刊ISSN1347-9032
微信扫码收藏此期刊
E-ISSN1349-7006
2023-2024最新影响因子
(数据来源于搜索引擎)
4.5 点击查看影响因子趋势图
实时影响因子 截止2024年10月29日:3.293
2023-2024自引率2.20%点击查看自引率趋势图
五年影响因子5.5
JCI期刊引文指标 1.01
h-index 129
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
9.901.6251.091
学科分区排名百分位
大类:Medicine
小类:Oncology
Q161 / 404
大类:Medicine
小类:Cancer Research
Q152 / 230

期刊简介
Cancer Science (formerly Japanese Journal of Cancer Research) is a monthly publication of the Japanese Cancer Association. First published in 1907, the Journal continues to publish original articles, editorials, and letters to the editor, describing original research in the fields of basic, translational and clinical cancer research. The Journal also accepts reports and case reports.

Cancer Science aims to present highly significant and timely findings that have a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal will not publish case reports that describe a rare tumor or condition without new findings to be added to previous reports; combination of different tumors without new suggestive findings for oncological research; remarkable effect of already known treatments without suggestive data to explain the exceptional result. Review articles may also be published.
期刊官方网站http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1349-7006
期刊投稿网址http://mc.manuscriptcentral.com/cas
期刊语言要求Language
Manuscripts must be written in American English and be grammatically and linguistically correct. Authors should seek assistance with style, grammar and vocabulary if necessary. Your manuscript may also be sent back to you for revision if the quality of English language is poor.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CANCER SCIENCE的语言要求,还能让CANCER SCIENCE编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CANCER SCIENCE编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( USD2600; GBP1650; EUR2350; )
文章处理费豁免:查看说明
其他费用:没有
期刊主题关键词:oncology、cancer research、palliative care、radiotherapy
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
通讯方式WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148
出版商Wiley-Blackwell
涉及的研究方向医学-肿瘤学
出版国家或地区JAPAN
出版语言English
出版周期Monthly
出版年份2003
年文章数 316点击查看年文章数趋势图
Gold OA文章占比73.61%
研究类文章占比:
文章 ÷(文章 + 综述)
92.41%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:ONCOLOGYSCIEQ178/322
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:ONCOLOGYSCIEQ179/322
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区2区1区
ONCOLOGY
肿瘤学
3区3区2区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 1区2区2区
ONCOLOGY
肿瘤学
2区3区2区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区2区3区
ONCOLOGY
肿瘤学
2区3区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1347-9032%5BISSN%5D
平均审稿速度网友分享经验:
平均2.0个月
平均录用比例网友分享经验:
约62.5%
版面费/APC文章处理费信息
文章处理费:需要( USD2600; GBP1650; EUR2350; )
文章处理费豁免:查看说明
其他费用:没有
LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦!
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在CANCER SCIENCE顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 CANCER SCIENCE期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 CANCER SCIENCE中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
CANCER SCIENCE上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    Nature Reviews Clinical Oncology12799.40
    NATURE REVIEWS CANCER396111.90
    ANNALS OF ONCOLOGY21063.90
    CANCER CELL29555.20
    JOURNAL OF CLINICAL ONCOLOGY49441.20
    LANCET ONCOLOGY27462.10
    CANCER RESEARCH41116.10
    SEMINARS IN CANCER BIOLOGY13426.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH6718.20
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE673064
    BIOMATERIALS564108
    BIOMEDICINE & PHARMACOTHERAPY548122
    Frontiers in Pharmacology512053
    Journal of Materials Chemistry B501778
    Frontiers in Immunology488366
    COMPUTERS IN BIOLOGY AND MEDICINE469163
    JOURNAL OF ETHNOPHARMACOLOGY462920
    COLLOIDS AND SURFACES B-BIOINTERFACES436753
    Frontiers in Oncology433549
  •  

    CANCER SCIENCE CANCER SCIENCE
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Distinct mechanisms of dysfunctional antigen-presenting DCs and monocytes by single-cell sequencing in multiple myeloma

    Author: Jiang, Jinxing; Xiang, Jing; Chen, Mengping; Wan, Yike; Zhong, Lu; Han, Xiaofeng; Chen, Xiaotong; Wang, Junying; Xiao, Fei; Liu, Jia; Li, Hua; Huang, Honghui; Hou, Jian
    Journal: CANCER SCIENCE. 2023; Vol. , Issue , pp. -. DOI: 10.1111/cas.15800
        PubMed      DOI
    2.Targeting the PTP1B-Bcr-Abl1 interaction for the degradation of T315I mutant Bcr-Abl1 in chronic myeloid leukemia

    Author: Elgehama, Ahmed; Wang, Yixuan; Yu, Ying; Zhou, Lin; Chen, Zhixiu; Wang, Liwei; Sun, Lijun; Gao, Jian; Yu, Biao; Shen, Yan; Xu, Qiang
    Journal: CANCER SCIENCE. 2023; Vol. 114, Issue 1, pp. 247-258. DOI: 10.1111/cas.15580
        PubMed      DOI
    3.Hypoxia-induced CXC chemokine ligand 14 expression drives protumorigenic effects through activation of insulin-like growth factor-1 receptor signaling in glioblastoma

    Author: Wei, Sung-Tai; Chiang, Jung-Ying; Wang, Hwai-Lee; Lei, Fu-Ju; Huang, Yen-Chih; Wang, Chi-Chung; Cho, Der-Yang; Hsieh, Chia-Hung
    Journal: CANCER SCIENCE. 2023; Vol. 114, Issue 1, pp. 174-186. DOI: 10.1111/cas.15587
        PubMed      DOI
    4.METTL3-mediated m6A mRNA contributes to the resistance of carbon-ion radiotherapy in non-small-cell lung cancer

    Author: Xu, Xiaofeng; Zhang, Peiru; Huang, Yangle; Shi, Weizhong; Mao, Jingfang; Ma, Ningyi; Kong, Lin; Guo, Lin; Liu, Jinlong; Chen, Jian; Lu, Renquan
    Journal: CANCER SCIENCE. 2023; Vol. 114, Issue 1, pp. 105-114. DOI: 10.1111/cas.15590
        PubMed      DOI
    5.Novel hKDR mouse model depicts the antiangiogenesis and apoptosis-promoting effects of neutralizing antibodies targeting vascular endothelial growth factor receptor 2

    Author: Cao, Yuan; Sun, Chunyun; Huo, Guitao; Wang, Huiyu; Wu, Yong; Wang, Fei; Liu, Susu; Zhai, Shijie; Zhang, Xiao; Zhao, Haoyang; Hu, Meiling; Gu, Wenda; Yang, Yanwei; Wang, Sanlong; Liang, Chunnan; Lyu, Jianjun; Lu, Tiangong; Wang, Youchun; Xie, Liangzhi; Fan, Changfa
    Journal: CANCER SCIENCE. 2023; Vol. 114, Issue 1, pp. 115-128. DOI: 10.1111/cas.15594
        PubMed      DOI
    6.N6-methyladenosine-modified HOTAIRM1 promotes vasculogenic mimicry formation in glioma

    Author: Wu, Zhangyi; Lin, Yihai; Wei, Nan
    Journal: CANCER SCIENCE. 2023; Vol. 114, Issue 1, pp. 129-141. DOI: 10.1111/cas.15578
        PubMed      DOI
    7.CXC chemokine ligand-10 promotes the accumulation of monocyte-like myeloid-derived suppressor cells by activating p38 MAPK signaling under tumor conditions

    Author: Sun, Yingying; Mo, Yan; Jiang, Shu; Shang, Chao; Feng, Yunpeng; Zeng, Xianlu
    Journal: CANCER SCIENCE. 2023; Vol. 114, Issue 1, pp. 142-151. DOI: 10.1111/cas.15598
        PubMed      DOI
    8.Multiomics analyses and machine learning of nuclear receptor coactivator 6 reveal its essential role in hepatocellular carcinoma

    Author: Fang, Yinghao; Xu, Yuyan; Liao, Wei; Ji, Tao; Yu, Linyuan; Li, Longhai; Pan, Mingxin; Yang, Dinghua
    Journal: CANCER SCIENCE. 2023; Vol. 114, Issue 1, pp. 75-90. DOI: 10.1111/cas.15577
        PubMed      DOI
    9.Oncogenic LINC00857 recruits TFAP2C to elevate FAT1 expression in gastric cancer

    Author: Zhang, Wenqing; Ji, Kaiyue; Min, Congcong; Zhang, Cuiping; Yang, Lin; Zhang, Qi; Tian, Zibin; Zhang, Mengyuan; Wang, Xinyu; Li, Xiaoyu
    Journal: CANCER SCIENCE. 2023; Vol. 114, Issue 1, pp. 63-74. DOI: 10.1111/cas.15394
        PubMed      DOI
    10.CDCA7 promotes TGF-beta-induced epithelial-mesenchymal transition via transcriptionally regulating Smad4/Smad7 in ESCC

    Author: Li, Hongyi; Wang, Shaojie; Li, Xiubo; Weng, Yongjia; Guo, Dinghe; Kong, Pengzhou; Cheng, Caixia; Wang, Yanqiang; Zhang, Ling; Cheng, Xiaolong; Cui, Yongping
    Journal: CANCER SCIENCE. 2023; Vol. 114, Issue 1, pp. 91-104. DOI: 10.1111/cas.15560
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    Living Reviews in Relativity069.90
    Living Reviews in Relativity7569.90
    Advanced Composites and Hybrid Materials026.00
    Kidney International Supplements2026.70
    Kidney International Supplements2426.70
    Wiley Interdisciplinary Reviews-Computational Molecular Science6228.90
    Military Medical Research038.40
    NUCLEIC ACIDS RESEARCH45227.10
    Environmental Chemistry Letters5032.00
    Journal of the National Comprehensive Cancer Network8820.20
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共11


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室